For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Your partner in science for end-to-end CRDMO solutions

Author Archives: Jubilantbiosys

A proud moment for Jubilant Biosys !!

Our partner ‘Inipharm’ has announced the initiation of clinical trials with a compound that was discovered at our integrated drug discovery site, Bengaluru.

Posted in News |

POSH [Prevention of Sexual Harassment]

Posted in Policies |

RICT 2024

Functional Area: Life Sciences

Posted in Events |

Leveraging the Orbitrap HRMS for met-ID & large molecule analysis

Posted in In-House Insights New |

Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders

Authors: Sven Ruf, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur, Mahanandeesha S. Hallur, Shilpa Rani, Rajendra Kristam, Srinivasan Swaminathan, Bharat Ravindra Zope, Pavan Kumar Gondrala, Indu Swamy, V. P. Rama Kishore Putta, Saravanan Kandan, Gernot Zech, Herman Schreuder, Christine Rudolph, Ralf Elvert, Joerg Czech, Swarnakumari Birudukota, M. Amir Siddiqui, Niranjan Naranapura Anand, Vishal Subhash Mane, Sreekanth Dittakavi, […]

Posted in Publications |

Annual Return

Annual Return FY-2021

Posted in Uncategorised |

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics.

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.

Posted in Press Releases |

Flow Chemistry as an additional tool in organic syntheis for MedChem projects

Posted in Whitepapers |

Enhancement of Structure based & Fragment Based Drug Discovery using Pioneer FE SPR System

Posted in Whitepapers |

ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score

Authors: K.V. Sanjay, Santosh Vishwakarma, Bharat Ravindra Zope, Vishal Subhash Mane, Sunil Mohire, Saravanakumar Dhakshinamoorthy

Posted in Publications |